Browsing by Subject "KMT2C"
Now showing items 1-1 of 1
Generating Tools to Investigate Infant Leukemia Disease Biology and Identify New Therapies Through Rapid Drug Screening. (2021-07-23)Infant Leukemia (IL) is a rare and aggressive congenital leukemia that is frequently caused by fusion genes involving lysine methyltransferase MLL (MLL1; KMT2A) and has a dismal prognosis. Further investigation into ...